Literature DB >> 10444023

Endothelin-1 and serotonin: mediators of primary and secondary pulmonary hypertension?

M R MacLean1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10444023     DOI： 10.1016/s0022-2143(99)90114-2

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN： 0022-2143


× No keyword cloud information.
  9 in total

Review 1.  5-hydroxytryptamine and the pulmonary circulation: receptors, transporters and relevance to pulmonary arterial hypertension.

Authors:  M R MacLean; P Herve; S Eddahibi; S Adnot
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

2.  Increased expression of the cGMP-inhibited cAMP-specific (PDE3) and cGMP binding cGMP-specific (PDE5) phosphodiesterases in models of pulmonary hypertension.

Authors:  Fiona Murray; Margaret R MacLean; Nigel J Pyne
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

Review 3.  The structural basis of pulmonary hypertension in chronic lung disease: remodelling, rarefaction or angiogenesis?

Authors:  Natalie Hopkins; Paul McLoughlin
Journal:  J Anat       Date:  2002-10       Impact factor: 2.610

4.  LU135252, an endothelin(A) receptor antagonist did not prevent pulmonary vascular remodelling or lung fibrosis in a rat model of myocardial infarction.

Authors:  Q T Nguyen; F Colombo; J L Rouleau; J Dupuis; A Calderone
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

5.  Pulmonary hypertension secondary to left ventricular dysfunction: the role of nitric oxide and endothelin-1 in the control of pulmonary vascular tone.

Authors:  Graeme A Deuchar; Andrew Docherty; Margaret R MacLean; Martin N Hicks
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

6.  An assessment of the role of the inhibitory gamma subunit of the retinal cyclic GMP phosphodiesterase and its effect on the p42/p44 mitogen-activated protein kinase pathway in animal and cellular models of pulmonary hypertension.

Authors:  Fiona Murray; Margaret R MacLean; Nigel J Pyne
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

7.  Increased contractile response to 5-hydroxytryptamine1-receptor stimulation in pulmonary arteries from chronic hypoxic rats: role of pharmacological synergy.

Authors:  M R MacLean; I Morecroft
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

8.  Risk factors for persistent pulmonary hypertension of the newborn.

Authors:  Cassidy Delaney; David N Cornfield
Journal:  Pulm Circ       Date:  2012 Jan-Mar       Impact factor: 3.017

9.  Risk factors and mortality among newborns with persistent pulmonary hypertension.

Authors:  Athar Razzaq; Ahmed Iqbal Quddusi; Naila Nizami
Journal:  Pak J Med Sci       Date:  2013-09       Impact factor: 1.088
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.